CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
CONQUEST develops a novel imaging technology using specially designed nanoparticles as contrast agents for ultrasound and MRI. This approach aims to improve the diagnosis of conditions like liver lesions while reducing costs and enhancing accessibility in medical imaging.
CONQUEST:
Enabling advanced medical imagingCONQUEST is formed around a new imaging technology platform.
The basis is the newly developed nanoparticles function as contrast agents for a variety of imaging modalities that are presently used in healthcare such as ultrasound and MRI.
In particular, the nanoparticles are a completely novel type of contrast agent for ultrasound imaging.
The high stability and long shelf life of the particles combined with visibility in ultrasound could allow applicati…
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
